Drug Profile
B 6107
Alternative Names: B6107Latest Information Update: 28 Apr 2020
Price :
$50
*
At a glance
- Originator Samyang Biopharmaceuticals Corporation
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Apr 2020 No recent reports of development identified for research development in Unspecified in South Korea (PO, Controlled release)
- 02 Mar 2016 Early research in Undefined indication in South Korea (PO) before March 2016